BOONE CAPITAL MANAGEMENT LLC
Filing Date
Global Rank
#4,242
/ 8,795
▲ 44
· as of Jun 2026
Top Industry
Biotechnology
51.7%
3Y Alpha vs SPY
-22.1%
Period ended 3 months ago
Filed Aug 14, 2026 · 54d
15 quarters · since Dec 2022
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
16 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
11.5%
−0.4 pts
Top 5
51.4%
−4.1 pts
Top 10
83.0%
−7.6 pts
HHI
794
Diversified−118
Portfolio Trend
15 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 93.5% | $399,946,255 |
| Industrials | 6.5% | $27,590,032 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
8 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | +110,891 | 339,720 | $25,302,345 | |
| TFX | Teleflex Inc | +108,596 | 387,388 | $49,105,302 | |
| KOD | Kodiak Sciences Inc. | +96,678 | 378,010 | $14,727,269 | |
| GRDN | Guardian Pharmacy Services, Inc. | +80,746 | 711,939 | $29,808,885 | |
| BMRN | Biomarin Pharmaceutical Inc | +35,348 | 583,219 | $33,371,791 | |
| CI | Cigna Group | +21,768 | 159,290 | $43,913,067 | |
| IONS | Ionis Pharmaceuticals Inc | +19,455 | 519,977 | $41,228,976 | |
| UNH | Unitedhealth Group Inc | +9,461 | 88,687 | $36,860,977 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| MIRM | Mirum Pharmaceuticals, Inc. | −5,595 | 415,641 | $48,659,091 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
7 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| VSTS | Vestis Corp | 1,900,140 | $27,590,032 | |
| PNTG | Pennant Group, Inc. | 515,818 | $19,059,475 | |
| GLUE | Monte Rosa Therapeutics, Inc. | 615,287 | $14,889,945 | |
| TNGX | Tango Therapeutics, Inc. | 455,605 | $14,242,212 | |
| KYMR | Kymera Therapeutics, Inc. | 113,173 | $12,977,547 | |
| CGEM | Cullinan Therapeutics, Inc. | 704,442 | $12,827,888 | |
| ANL | Adlai Nortye Group Ltd. | 258,390 | $2,971,485 | |
| No positions match the current search. | ||||
16 tracked positions ·
$427,536,287 total
· filing declares
16 positions · $427,536,296
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| TFX |
Teleflex Inc
Healthcare
|
Added | 387,388 | $49,105,302 | 11.49% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Reduced | 415,641 | $48,659,091 | 11.38% | |
| CI |
Cigna Group
Healthcare
|
Added | 159,290 | $43,913,067 | 10.27% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Added | 519,977 | $41,228,976 | 9.64% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Added | 88,687 | $36,860,977 | 8.62% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Added | 583,219 | $33,371,791 | 7.81% | |
| GRDN |
Guardian Pharmacy Services, Inc.
Healthcare
|
Added | 711,939 | $29,808,885 | 6.97% | |
| VSTS |
Vestis Corp
Industrials
|
NEW | 1,900,140 | $27,590,032 | 6.45% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Added | 339,720 | $25,302,345 | 5.92% | |
| PNTG |
Pennant Group, Inc.
Healthcare
|
NEW | 515,818 | $19,059,475 | 4.46% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
NEW | 615,287 | $14,889,945 | 3.48% | |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
Added | 378,010 | $14,727,269 | 3.44% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
NEW | 455,605 | $14,242,212 | 3.33% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
NEW | 113,173 | $12,977,547 | 3.04% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
NEW | 704,442 | $12,827,888 | 3.00% | |
| ANL |
Adlai Nortye Group Ltd.
Healthcare
|
NEW | 258,390 | $2,971,485 | 0.70% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.